Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MCHR1 antagonist shows notable selectivity and good PK profile

March 17, 2005

First data describing MB-06322, an antidiabetic agent in phase II trials

March 16, 2005

New compounds for the treatment of diabetes claimed by Allergan

March 16, 2005

WNT antagonism via sFRPs: possible therapy for promoting chondrogenesis

March 16, 2005

Role for endogenous opioids in perinatal skeletal development

March 16, 2005

Enrollment completed in phase I study of CTCE-0214

March 16, 2005

Hematide stimulates production of red blood cells in phase I study

March 16, 2005

MC4 receptor agonists useful for treating diabetes reported by Eli Lilly

March 15, 2005

Glycogen synthase kinase-3 inhibitors described in a patent

March 15, 2005

Roche claimes new agents for the treatment of diabetes and obesity

March 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...